23 September 2019 in BioMed Research International
Drug resistance to temozolomide (TMZ) contributes to the majority of tumor recurrence and treatment failure in patients with glioblastoma multiforme (GBM). Autophagy has been reported to play a role in chemoresistance in various types of cancer, including GBM. The anticancer effect of statins is arousing great research interests and has been demonstrated to modulate autophagic function. In this study, we investigated the combinational effects of lovastatin and TMZ on treating U87 and U251 GBM cell lines. Cytotoxicity was measured by MTT and colony formation assays; apoptosis was measured by flow cytometry; the cellular autophagic function was detected by the EGFP-mRFP-LC3 reporter and western blot assay. The results showed that lovastatin might enhance the cytotoxicity of TMZ, increase the TMZ-induced cellular apoptosis, and impair the autophagic flux in GBM cells. Lovastatin triggered autophagy initiation possibly by inhibiting the Akt/mTOR signaling pathway. Moreover, lovastatin might impair the autophagosome-lysosome fusion machinery by suppressing LAMP2 and dynein. These results suggested that lovastatin could enhance the chemotherapy efficacy of TMZ in treating GBM cells. The mechanism may be associated with impaired autophagic flux and thereby the enhancement of cellular apoptosis. Combining TMZ with lovastatin could be a promising strategy for GBM treatment.
1 April 2020 in Cancer Letters
28 June 2018 in BioMed Research International
Temozolomide (TMZ) is the first-line chemotherapeutic agent in the treatment of glioblastoma multiforme (GBM). Despite its cytotoxic effect, TMZ also induces cell cycle arrest that may lead to the development of chemoresistance and eventual tumor recurrence. Caffeine, a widely consumed neurostimulant, shows anticancer activities and is reported to work synergistically with cisplatin and camptothecin. The present study aimed to investigate the effects and the mechanisms of action of caffeine used in combination with TMZ in U87-MG GBM cells. As anticipated, TMZ caused DNA damage mediated by the ATM/p53/p21 signaling pathway and induced significant G2 delay. Concurrent treatment with caffeine repressed proliferation and lowered clonogenic capacity on MTT and colony formation assays, respectively. Mechanistic study showed that coadministration of caffeine and TMZ suppressed the phosphorylation of ATM and p53 and downregulated p21 expression, thus releasing DNA-damaged cells from G2 arrest into premature mitosis. Cell cycle analysis demonstrated that the proportion of cells arrested in G2 phase decreased when caffeine was administered together with TMZ; at the same time, the amount of cells with micronucleation and multipolar spindle poles increased, indicative of enhanced mitotic cell death. Pretreatment of cells with caffeine further enhanced mitotic catastrophe development in combined treatment and sensitized cells to apoptosis when followed by TMZ alone. In conclusion, our study demonstrated that caffeine enhanced the efficacy of TMZ through mitotic cell death by impeding ATM/p53/p21-mediated G2 arrest.
13 November 2026 in Neural Regeneration Research
Spinal cord injury produces persistent neurological dysfunction because injured central axons have limited capacity for structural repair and because secondary tissue changes constrain neural plasticity. Low-intensity pulsed ultrasound is a noninvasive physical stimulation strategy with emerging neuroregenerative potential, but the molecular components associated with its effects after spinal cord injury remain incompletely defined. In a mouse unilateral T9–T10 spinal cord hemisection model, we first compared 30, 45, and 60 mW/cm 2 low-intensity pulsed ultrasound and selected 45 mW/cm 2 as the working regimen for subsequent experiments. Low-intensity pulsed ultrasound improved locomotor and sensory performance, motor-evoked potential conduction, tractography-based structural features, neurofilament-200-positive axonal organization, and axon-myelin ultrastructure. Labelfree proteomic profiling of lesion-containing spinal cord tissue identified coordinated changes in neural and axon-associated programs and prioritized Rtn3 as a low-intensity pulsed ultrasound-responsive candidate; peptide-level evidence supported the direction of the protein-level change. Exploratory reanalysis of public single-cell RNA-sequencing datasets was used only to provide cell-type context at the Rtn3 transcript level. Subsequent isoform-focused experiments showed that the long Rtn3 isoform, Rtn3L, decreased after injury and was partially restored by low-intensity pulsed ultrasound in vivo and in nerve growth factor-differentiated PC12 cells. Adeno-associated virus-mediated Rtn3L overexpression reproduced several low-intensity pulsed ultrasound-associated behavioral, electrophysiological, imaging, and axon-myelin structural features, whereas Rtn3L knockdown attenuated multiple responses to low-intensity pulsed ultrasound. Parallel gain- and loss-of-function experiments in PC12 cells showed corresponding changes in neurite outgrowth. These findings identify Rtn3L as a functionally relevant contributor to low-intensity pulsed ultrasound-associated axonal remodeling after spinal cord injury.